Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lilian Varga

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Biologics in Therapy|February 4, 2014
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor DeficiencyHenriette Farkas, Lilian Varga
Expert Review of Clinical Immunology|May 19, 2010
Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitorLilian Varga, Henriette Farkas
Current Protocols in Immunology|April 25, 2008
Assays for complement proteins encoded in the class III region of human MHCLilian Varga, George Füst
Expert Review of Clinical Immunology|March 24, 2011
rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiencyLilian Varga, Henriette Farkas
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2013
C1 inhibitor: quantification and purificationLilian Varga, József Dobó
Clinical, Cosmetic and Investigational Dermatology|July 16, 2011
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiencyHenriette Farkas, Lilian Varga
Biologics in Therapy|August 14, 2016
Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor DeficiencyHenriette Farkas, Lilian Varga
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
The Hungarian HAE experienceHenriette Farkas, Lilian Varga
British Journal of Haematology|May 23, 2012
The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathiesZoltán Prohászka, Lilian Varga, George Füst
Molecular Immunology|November 30, 2010
Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedemaLilian Varga, George Füst, Dorottya Csuka, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Biologics in Therapy|February 4, 2014
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor DeficiencyHenriette Farkas, Lilian Varga
Expert Review of Clinical Immunology|May 19, 2010
Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitorLilian Varga, Henriette Farkas
Current Protocols in Immunology|April 25, 2008
Assays for complement proteins encoded in the class III region of human MHCLilian Varga, George Füst
Expert Review of Clinical Immunology|March 24, 2011
rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiencyLilian Varga, Henriette Farkas
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2013
C1 inhibitor: quantification and purificationLilian Varga, József Dobó
Clinical, Cosmetic and Investigational Dermatology|July 16, 2011
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiencyHenriette Farkas, Lilian Varga
Biologics in Therapy|August 14, 2016
Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor DeficiencyHenriette Farkas, Lilian Varga
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
The Hungarian HAE experienceHenriette Farkas, Lilian Varga
British Journal of Haematology|May 23, 2012
The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathiesZoltán Prohászka, Lilian Varga, George Füst
Molecular Immunology|November 30, 2010
Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedemaLilian Varga, George Füst, Dorottya Csuka, et al.
Pageof 11